Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Etoposide Selectively Ablates Activated T Cells To Control the Immunoregulatory Disorder Hemophagocytic Lymphohistiocytosis

Published:2013-11-20 Issue:1 Volume:192 Page:84-91
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Johnson Theodore S.,Terrell Catherine E.,Millen Scott H.,Katz Jonathan D.,Hildeman David A.,Jordan Michael B.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference45 articles.

1. How I treat hemophagocytic lymphohistiocytosis

2. An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder

3. Perforin is a critical physiologic regulator of T-cell activation

4. Hemophagocytosis causes a consumptive anemia of inflammation

5. Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8+ T cells and dendritic cells

Cited by 162 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Study design and rationale for IFCT- 2203 TAXIO: A study that aims to evaluate the effectiveness of a first-line chemotherapy regimen without etoposide, combined with durvalumab, for patients with extensive disease small cell lung cancer;Respiratory Medicine and Research;2024-11

2. Self‐Assembly of Biocompatible Core‐Shell Nanocapsules with Tunable Surface Functionality by Microfluidics for Enhanced Drug Delivery;Advanced Functional Materials;2024-08-02

3. Riding the storm: managing cytokine-related toxicities in CAR-T cell therapy;Seminars in Immunopathology;2024-07-16

4. Network-based Multi-omics Disease–Drug Associations Reveal Drug Repurposing Candidates for Covid-19 Disease Phases;Drug Repurposing;2024-07-03

5. Differential effects of itacitinib, fedratinib, and ruxolitinib in mouse models of hemophagocytic lymphohistiocytosis;Blood;2024-06-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3